Saeed Abdulrahman Ibrahiem, Al-Mueilo Samir H, Bokhary Huda A, Ladipo Gani O A, Al-Rubaish Abdulla
King Fahd Hospital of the University, P.O. Box 40032, Al Khobar 31952, Saudi Arabia.
J Infect Chemother. 2002 Sep;8(3):242-6. doi: 10.1007/s10156-002-0184-8.
The objective of this study was to describe hemodialysis vascular-access related infections that occurred in hemodialysis patients over an 18-month period. The study is a prospective descriptive analysis of incidence infection rates in a hemodialysis unit in a tertiary-care medical center. Prospective surveillance for hemodialysis vascular access-related infection was performed for all patients undergoing hemodialysis from November 1999 through April 2001 at King Fahd Hospital of King Faisal University, Al-Khobar, Saudi Arabia. The total number of dialysis sessions was calculated. The type of vascular access was noted. Cultures were obtained and all infections were recorded and infection rates were calculated. There were 9627 hemodialysis sessions (5437 via permanent fistulae or grafts, 2409 via temporary central catheters, and 1781 via permanent tunneled catheters) during the 18-month study period. We identified a total of 109 infections, for a rate of 11.32/1000 dialysis sessions (ds). Of the 109, 23 involved permanent fistulae or grafts (4.23/1000 ds); 18 involved permanent-tunneled central catheter infections (10.1/1000 ds); and 68 involved temporary-catheter infections (28.23/1000 ds). There were 38 bloodstream infections (3.95/1000 ds) and 34 episodes of clinical sepsis (3.53/1000 ds). Seventy-one vascular access infections without bacteremia were identified (7.38/1000 ds), including 16 permanent-fistulae or graft infections (2.94/1000 ds), 7 permanent-tunneled central catheter infections (3.93/1000 ds), and 48 temporary-catheter infections (19.92/1000 ds). Staphylococcal organisms were responsible for 77% of the infections, with Staphylococcus epidermidis being the strain most commonly implicated. Gram-negative organisms were responsible for 23% of the infections. In conclusion, infection rates were highest in hemodialysis patients with temporary vascular access, compared with rates in those with permanent arteriovenous fistulae and synthetic grafts. Most of the bacterial organisms isolated from the vascular access sites were gram-positive cocci, with S. epidermidis accounting for 50% of the organisms. The rate of infection with gram-negative bacilli was higher than in other reports. Our greater dependence on central venous catheters, due to local factors, coupled with the immune-compromising comorbid conditions of our patients, may be contributory to the pattern of infection reported. Delays in the creation of vascular grafts for hemodialysis access should be avoided.
本研究的目的是描述在18个月期间血液透析患者中发生的与血液透析血管通路相关的感染情况。该研究是对一家三级医疗中心血液透析单元感染发病率的前瞻性描述性分析。1999年11月至2001年4月期间,在沙特阿拉伯胡拜尔法赫德国王大学费萨尔国王医院,对所有接受血液透析的患者进行了与血液透析血管通路相关感染的前瞻性监测。计算了透析疗程的总数,记录了血管通路的类型,进行了培养,记录了所有感染情况并计算了感染率。在18个月的研究期间,共有9627次血液透析疗程(5437次通过永久性动静脉内瘘或移植物,2409次通过临时性中心静脉导管,1781次通过永久性隧道式导管)。我们共识别出109例感染,感染率为11.32/1000透析疗程(ds)。在这109例感染中,23例涉及永久性动静脉内瘘或移植物(4.23/1000 ds);18例涉及永久性隧道式中心静脉导管感染(10.1/1000 ds);68例涉及临时性导管感染(28.23/1000 ds)。有38例血流感染(3.95/1000 ds)和34例临床脓毒症发作(3.53/1000 ds)。识别出71例无菌血症的血管通路感染(7.38/1000 ds),包括16例永久性动静脉内瘘或移植物感染(2.94/1000 ds),7例永久性隧道式中心静脉导管感染(3.93/1000 ds),以及48例临时性导管感染(19.92/1000 ds)。葡萄球菌属微生物导致了77%的感染,其中表皮葡萄球菌是最常见的菌株。革兰氏阴性菌导致了23%的感染。总之,与永久性动静脉内瘘和人工移植物患者相比,临时性血管通路的血液透析患者感染率最高。从血管通路部位分离出的大多数细菌是革兰氏阳性球菌,表皮葡萄球菌占分离出微生物的50%。革兰氏阴性杆菌的感染率高于其他报告。由于当地因素,我们对中心静脉导管的依赖性更强,再加上患者的免疫功能低下合并症,可能是导致所报告感染模式的原因。应避免延迟建立用于血液透析通路的血管移植物。